97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

19 trials found

diseases per page:

Showing 1 to 10 of 19 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05242484 (ClinicalTrials.gov)	May 20, 2022	15/2/2022	A Study of Combination Therapy With Guselkumaband Golimumab in Participants With Moderately to Sever ...	A Phase 2b Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter Study to Evaluat ...	Colitis, Ulcerative	Biological: Guselkumab;Biological: Golimumab;Biological: JNJ-78934804	Janssen Research & Development, LLC	NULL	Not yet recruiting	18 Years	65 Years	All	500	Phase 2	United States
2	EUCTR2018-004002-25-SK (EUCTR)	28/05/2021	13/01/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	United States;Serbia;Portugal;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
3	EUCTR2018-004002-25-LV (EUCTR)	27/05/2021	02/02/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	950	Phase 2;Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
4	EUCTR2018-004002-25-NL (EUCTR)	06/07/2020	17/09/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
5	JPRN-JapicCTI-194980	22/5/2020	30/09/2019	A Study of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Ulcerative Colitis	Intervention name : Guselkumab INN of the intervention : Guselkumab Dosage And administration of the i ...	Janssen Pharmaceutical K.K.	NULL	recruiting	18		BOTH	1000	Phase 2-3	Japan, Asia except Japan, North America, Europe
6	EUCTR2018-004002-25-BG (EUCTR)	13/05/2020	24/02/2020	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Italy;France;Malaysia ...
7	EUCTR2018-004002-25-DE (EUCTR)	07/04/2020	23/08/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	United States;Portugal;Taiwan;Hong Kong;Slovakia;Spain;Ukraine;Russian Federation;Israel;Italy;Franc ...
8	EUCTR2018-004002-25-ES (EUCTR)	28/02/2020	04/09/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Portugal;United States;Taiwan;Hong Kong;Thailand;Spain;Ukraine;Russian Federation;Israel;Italy;Franc ...
9	EUCTR2018-004002-25-PT (EUCTR)	03/02/2020	06/08/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	950	Phase 2;Phase 3	Portugal;United States;Taiwan;Hong Kong;Spain;Thailand;Ukraine;Russian Federation;Israel;Italy;Franc ...
10	EUCTR2018-004002-25-IT (EUCTR)	24/10/2019	17/06/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: GUSELKUMAB Product Code: [CNTO1959] INN or Proposed INN: GUSELKUMAB Other descriptive nam ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	950	Phase 3	United States;Bulgaria;Germany;Japan;Sweden;Poland;Belgium;Argentina;Canada;Hungary;United Kingdom;T ...

First Previous1 2Next Last